These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4688 related articles for article (PubMed ID: 6414503)

  • 21. Transformation of murine LMTK- cells with purified HLA class I genes. I. Modification of conformation of murine beta 2-microglobulin upon its association with HLA heavy chains.
    Lemonnier FA; Le Bouteiller PP; Malissen B; Golstein P; Malissen M; Mishal Z; Caillol DH; Jordan BR; Kourilsky FM
    J Immunol; 1983 Mar; 130(3):1432-8. PubMed ID: 6185587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coexpression of the human HLA-A2 or HLA-B7 heavy chain gene and human beta 2-microglobulin gene in L cells.
    Bernabeu C; Maziarz R; Spits H; de Vries J; Burakoff SJ; Terhorst C
    J Immunol; 1984 Dec; 133(6):3188-94. PubMed ID: 6436376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histophotometric quantification of protein and reactive proteinthiols in invasive carcinomas of the skin.
    Nöhammer G; Schauenstein E; Soyer HW; Kresbach H
    Histochemistry; 1986; 85(5):437-8. PubMed ID: 2430917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of HLA heavy chain and beta 2-microglobulin in HLA negative tumours.
    Cabrera T; Concha A; Ruiz-Cabello F; Garrido F
    Scand J Immunol; 1991 Aug; 34(2):147-52. PubMed ID: 1866599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limitation of differential expression of HLA-A,B,C antigens on choriocarcinoma cell lines by messenger RNA for HLA heavy chain but not by beta 2-microglobulin.
    Kawata M; Sizer K; Sekiya S; Parnes JR; Herzenberg LA
    Cancer Res; 1984 Sep; 44(9):4011-6. PubMed ID: 6204750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the statistics of 32P enrichment in skin tumours.
    Mayer A; Zaránd P; Polgár I; Hermann A
    Strahlentherapie; 1983 Jun; 159(6):348-50. PubMed ID: 6879616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of beta2 microglobulin from the cell surface of cutaneous malignant and premalignant lesions.
    Turbitt ML; Mackie RM
    Br J Dermatol; 1981 May; 104(5):507-13. PubMed ID: 6165372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes in the levels of soluble HLA antigens and their light chains (beta 2 microglobulin) in rheumatoid arthritis and systemic lupus erythematosus].
    Konenkov VI; Prokof'ev VF; Glazycheva IIu; Kozhevnikov VS; Nuamov IuN
    Ter Arkh; 1986; 58(7):57-9. PubMed ID: 3532402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens.
    Natali PG; Bigotti A; Cavaliere R; Nicotra MR; Ferrone S
    J Natl Cancer Inst; 1984 Jul; 73(1):13-24. PubMed ID: 6376904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of the ELISA to detect and quantify histocompatibility antigens and their subunits.
    Ferreira A; Revilla Y; Bootello A; Gonzalez-Porqué P
    J Immunol Methods; 1983 Dec; 65(3):373-81. PubMed ID: 6418822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of monoclonal antibodies inhibits dissociation but not exchange of HLA and beta 2-microglobulin.
    Parham P
    Hum Immunol; 1983 Nov; 8(3):207-15. PubMed ID: 6358149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered expression of beta-2-microglobulin in basaloid proliferations overlying dermatofibromas.
    Rossen K; Hou-Jensen K; Werdelin O
    Acta Derm Venereol; 1993 Dec; 73(6):419-21. PubMed ID: 7906451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [X-ray microanalysis of epitheliomas and melanomas: is the Cu/Zn index a prognostic parameter? Preliminary note].
    Calap J; Vilches J; Peris J; Gómez S; Martínez A
    Med Cutan Ibero Lat Am; 1986; 14(1):9-12. PubMed ID: 3526039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical study of HLA antigens and lymphocyte infiltration in melanocytic tumors.
    Kageshita T; Nagano H; Johno M; Ono T; Arao T; Imai K
    J Dermatol; 1986 Jun; 13(3):179-84. PubMed ID: 3537044
    [No Abstract]   [Full Text] [Related]  

  • 35. Alterations of HLA class I and II antigen expression in preinvasive, invasive and metastatic cervical cancers.
    Ryu KS; Lee YS; Kim BK; Park YG; Kim YW; Hur SY; Kim TE; Kim IK; Kim JW
    Exp Mol Med; 2001 Sep; 33(3):136-44. PubMed ID: 11642549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association with beta 2-microglobulin controls the expression of transfected human class I genes.
    Rein RS; Seemann GH; Neefjes JJ; Hochstenbach FM; Stam NJ; Ploegh HL
    J Immunol; 1987 Feb; 138(4):1178-83. PubMed ID: 3543123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of synthesis and expression of H-2 heavy chain and beta-2 microglobulin in AKR leukemias.
    Schmidt W; Henseling U; Bevec D; Alonzo AD; Festenstein H
    Immunogenetics; 1985; 22(5):483-94. PubMed ID: 2415450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissociation and exchange of the beta 2-microglobulin subunit of HLA-A and HLA-B antigens.
    Hyafil F; Strominger JL
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5834-8. PubMed ID: 93282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Localization of integrin receptors for fibronectin, collagen, and laminin in human skin. Variable expression in basal and squamous cell carcinomas.
    Peltonen J; Larjava H; Jaakkola S; Gralnick H; Akiyama SK; Yamada SS; Yamada KM; Uitto J
    J Clin Invest; 1989 Dec; 84(6):1916-23. PubMed ID: 2556449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 235.